Iron Metabolism & Related Disorders

Home Sign In About Curriculum Ask the Experts New! Additional Information Target Audience Programme Goal Learning Objectives Certificate Requirements Faculty Roster Disclosures Technical Requirements

The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from

Created in consultation with
Projects In Knowledge^®, developers of certificate programs in medicine.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

Course materials have been developed for use outside of the United States.

Have a question?
Ask the Experts!

View information by clicking on column heads and/or using drop down boxes below.

Curriculum 4 Curriculum 3 Curriculum 2 Curriculum 1
	TITLE	FACULTY	TOPIC	DISEASE STATE
	Controversies in Iron Chelation in Myelodysplastic Syndromes —Audio Interview (Jul 2010) 1956	Giagounidis Leitch	Managing Side Effects and Non-Compliance	Myelodysplastic Syndromes

	2010 Conversations With the Experts: Management of Iron Overload —Video (Jul 2010) 1952	Porter Gattermann Inati	Iron Chelation Therapy Treatment and Monitoring of Iron Overload	Myelodysplastic Syndromes Sickle Cell Disease Thalassaemia Iron Deficiency Anaemia/Rare Anaemia

	Nonresponders to Iron Chelation Therapy —Webcast (Mar 2010) 1953	Porter Lin	Iron Chelation Therapy Managing Side Effects and Non-Compliance Case Study	Iron Deficiency Anaemia/Rare Anaemia

	Series of 10 Reports from the 51st American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana 2009 —Meeting Coverage (Jan 2010) 1950	Other	Iron Toxicity and Clinical Sequelae Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia

	Iron Chelator Basics: Emerging Data —Webcast (Dec 2009) 1919	Pietrangelo Piperno	Iron Metabolism/Regulation Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Iron Chelation Therapy Treatment and Monitoring of Iron Overload	Iron Deficiency Anaemia/Rare Anaemia Iron Metabolism/Regulation

	Iron Overload Case Library II, Case 4: Noncompliance with Iron Chelation Therapy in an Adolescent with Thalassaemia Major —Webcast (Nov 2009) 1928.04	Inati	Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance Case Study	Thalassaemia

	Iron Overload Case Library II, Case 3: The Role of Iron Chelation in High-Risk Myelodysplastic Syndromes Before Allogeneic Haematopoietic Stem Cell Transplant —Webcast (Nov 2009) 1928.03	Giagounidis	Iron Toxicity and Clinical Sequelae Iron Chelation Therapy Treatment and Monitoring of Iron Overload Case Study	Myelodysplastic Syndromes

	Update on Microcytic Anaemias —Webcast (Oct 2009) 1903	Beris Iolascon	Iron Metabolism/Regulation Epidemiology & Pathology	Iron Deficiency Anaemia/Rare Anaemia Iron Metabolism/Regulation

	Iron Overload Case Library II, Case 2: Adjusting Chelator Dose in Response to Adverse Events in a Patient with Sickle Cell Disease —Webcast (Oct 2009) 1928.02	de Montalembert	Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance Case Study	Sickle Cell Disease

	Update on Imaging: Detection of Iron in Liver and Heart —Webcast (Oct 2009) 1918	St. Pierre	Iron Toxicity and Clinical Sequelae Diagnosis of Iron Overload	Iron Deficiency Anaemia/Rare Anaemia

	Update on Iron Toxicity in Myelodysplastic Syndromes —Webcast (Sep 2009) 1917	Giagounidis Roghi	Iron Metabolism/Regulation Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Iron Chelation Therapy	Myelodysplastic Syndromes Iron Metabolism/Regulation

	Iron Overload Case Library II, Case 1: Managing Iron Overload in a Patient with Transfusion-Independent Thalassaemia Intermedia —Webcast (Sep 2009) 1928.01	Taher	Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance Case Study	Thalassaemia

	Update on Hepcidin Regulation in Different Disorders —Webcast (Jul 2009) 1916	Brissot	Iron Metabolism/Regulation Epidemiology & Pathology	Hereditary Haemochromatosis Iron Metabolism/Regulation

	Clinical Trial Updates: What Do the Data Say About the Management of Iron Overload? —Video (Jul 2009) 1920	Cappellini Giagounidis Taher	Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload	Myelodysplastic Syndromes Thalassaemia Iron Metabolism/Regulation

	Overview of Myelodysplastic Syndromes with Focus on Iron —Webcast (May 2009) 1902	Gattermann	Iron Metabolism/Regulation Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Iron Chelation Therapy Treatment and Monitoring of Iron Overload	Myelodysplastic Syndromes Iron Metabolism/Regulation

	Series of 10 Reports from the 50th American Society of Hematology (ASH) Annual Meeting and Exposition in San Francisco, California 2008 —Meeting Coverage (Jan 2009) 1888	Other	Iron Toxicity and Clinical Sequelae Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance	Myelodysplastic Syndromes Thalassaemia Iron Deficiency Anaemia/Rare Anaemia

	Diagnosis of Iron Overload II —Webcast (Apr 2009) 1850	Brissot Giagounidis Taher	Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload Case Study	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia Iron Deficiency Anaemia/Rare Anaemia

	Epidemiology and Disease Pathophysiology: Thalassaemia II —DownloadablePDF (Mar 2009) 1846.01	Other	Epidemiology & Pathology	Thalassaemia

	Iron Chelation Basics —Webcast (Dec 2008) 1853	Taher	Iron Chelation Therapy	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia Iron Deficiency Anaemia/Rare Anaemia

	Iron Toxicity and Clinical Sequelae II —Audio Interview (Nov 2008) 1849	Cappellini Wood Pietrangelo Chatterjee	Iron Toxicity and Clinical Sequelae Iron Chelation Therapy	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia Iron Deficiency Anaemia/Rare Anaemia

	Genetic Forms of Iron Deficiency Anaemia —Webcast (Sep 2008) 1848	Beris	Iron Metabolism/Regulation Epidemiology & Pathology Treatment and Monitoring of Iron Overload Case Study	Iron Deficiency Anaemia/Rare Anaemia Iron Metabolism/Regulation

	Molecular Pathophysiology of Iron Disorders —Webcast (Jul 2008) 1847	Hershko Ganz	Iron Metabolism/Regulation Epidemiology & Pathology	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia Iron Metabolism/Regulation

	Conversations With the Experts: Management of Iron Overload —Video (Jul 2008) 1854	Brissot Giagounidis Taher Porter	Iron Metabolism/Regulation Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia Iron Deficiency Anaemia/Rare Anaemia Iron Metabolism/Regulation

	Iron Overload Case Library, Case 4: Rash and Low T2* in a Paediatric Thalassaemia Patient —Webcast (Jun 2008) 1865.04	Taher	Iron Metabolism/Regulation Epidemiology & Pathology Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance Case Study	Thalassaemia Iron Metabolism/Regulation

	Iron Overload Case Library, Case 3: Dose Titration in a Paediatric Patient with Sickle Cell Disease —Webcast (Jun 2008) 1865.03	de Montalembert	Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance Case Study	Sickle Cell Disease

	Iron Overload Case Library, Case 2: Dose Titration in a Patient with Myelodysplastic Syndromes —Webcast (Jun 2008) 1865.02	Giagounidis	Iron Toxicity and Clinical Sequelae Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance Case Study	Myelodysplastic Syndromes

	Iron Overload Case Library, Case 1: Dose Adjustment/Non-Compliance in a Thalassaemia Patient —Webcast (Jun 2008) 1865.01	Taher	Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance Case Study	Thalassaemia

	Indications for Successful Iron Overload Treatments and Monitoring: Other Anaemias —Webcast (Dec 2008) 1827	Inati	Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload	Iron Deficiency Anaemia/Rare Anaemia

	Indications for Successful Iron Overload Treatments and Monitoring: Myelodysplastic Syndromes —Webcast (Mar 2008) 1824	Gattermann	Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Diagnosis of Iron Overload Treatment and Monitoring of Iron Overload	Myelodysplastic Syndromes

	Iron Toxicity and Clinical Sequelae —Webcast (Mar 2008) 1821	Porter	Iron Metabolism/Regulation Epidemiology & Pathology Iron Toxicity and Clinical Sequelae	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia Iron Deficiency Anaemia/Rare Anaemia Iron Metabolism/Regulation

	Indications for Successful Iron Overload Treatments and Monitoring: Sickle Cell Disease —Webcast (Mar 2008) 1825	de Montalembert	Iron Toxicity and Clinical Sequelae	Sickle Cell Disease

	Iron Toxicity and Clinical Sequelae —Webcast (Mar 2008) 1821	Porter	Iron Toxicity and Clinical Sequelae	Hereditary Haemochromatosis Thalassaemia Iron Deficiency Anaemia/Rare Anaemia Iron Metabolism/Regulation

	Indications for Successful Iron Overload Treatments and Monitoring: Sickle Cell Disease —Webcast (Mar 2008) 1825	de Montalembert	Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload Managing Side Effects and Non-Compliance	Sickle Cell Disease

	Indications for Successful Iron Overload Treatments and Monitoring: Thalassaemia —Webcast (Feb 2008) 1826	Cappellini	Iron Toxicity and Clinical Sequelae Iron Chelation Therapy Treatment and Monitoring of Iron Overload	Thalassaemia

	Indications for Successful Iron Overload Treatments and Monitoring: Hereditary Haemochromatosis —Webcast (Feb 2008) 1828	Brissot	Iron Metabolism/Regulation Iron Chelation Therapy Treatment and Monitoring of Iron Overload	Hereditary Haemochromatosis Iron Metabolism/Regulation

	Iron Chelation Basics —Webcast (Feb 2008) 1823	Porter	Iron Chelation Therapy	Thalassaemia Iron Deficiency Anaemia/Rare Anaemia

	Diagnosis of Iron Overload —Webcast (Feb 2008) 1822	Cappellini	Iron Metabolism/Regulation Epidemiology & Pathology Iron Toxicity and Clinical Sequelae Diagnosis of Iron Overload	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia Iron Deficiency Anaemia/Rare Anaemia Iron Metabolism/Regulation

	Iron Deficiency: Clinical Sequelae and Diagnosis —Webcast (Feb 2008) 1820	Beris	Epidemiology & Pathology	Iron Deficiency Anaemia/Rare Anaemia Iron Metabolism/Regulation

	Epidemiology and Disease Pathophysiology: Myelodysplastic Syndromes —DownloadablePDF (Feb 2008) 1819.04	Other	Epidemiology & Pathology	Myelodysplastic Syndromes

	Epidemiology and Disease Pathophysiology: Sickle Cell Disease —DownloadablePDF (Nov 2007) 1819.03	Beris	Epidemiology & Pathology Iron Toxicity and Clinical Sequelae	Sickle Cell Disease

	Epidemiology and Disease Pathophysiology: Other Anaemias —Webcast (Nov 2007) 1818	Taher	Epidemiology & Pathology Iron Chelation Therapy	Myelodysplastic Syndromes Thalassaemia Iron Deficiency Anaemia/Rare Anaemia

	Epidemiology and Disease Pathophysiology: Hereditary Haemochromatosis —Webcast (Oct 2007) 1819	Brissot	Iron Metabolism/Regulation Epidemiology & Pathology Diagnosis of Iron Overload Treatment and Monitoring of Iron Overload	Hereditary Haemochromatosis Iron Metabolism/Regulation

	Epidemiology and Disease Pathophysiology: Thalassaemia —Webcast (Sep 2007) 1817	Taher	Epidemiology & Pathology Diagnosis of Iron Overload Iron Chelation Therapy Treatment and Monitoring of Iron Overload	Thalassaemia

	End-Organ Damage Resulting from Accumulation of Iron in Cells —Webcast (May 2007) 1798.01	Brissot	Iron Metabolism/Regulation Epidemiology & Pathology Iron Toxicity and Clinical Sequelae	Myelodysplastic Syndromes Sickle Cell Disease Hereditary Haemochromatosis Thalassaemia Iron Metabolism/Regulation

ESH-Centre Hayem, Hôspital Saint-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France - Contacts